Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0404-2024Class II

SENTIERO SCREENING, mobile medical devices for hearing examinations, Model Number SOH100098, Part Number...

Path / initiated 2023-09-26 / Open, Classified

PATH began a recall of SENTIERO SCREENING, mobile medical devices for hearing examinations, Model Number SOH100098, Part Number 100098-S on . FDA classified it as Class II and gives the reason as "Affected lots of product may experience technical distortions to a greater extent than expected". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-0404-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Path
Product
SENTIERO SCREENING, mobile medical devices for hearing examinations, Model Number SOH100098, Part Number 100098-S
Product code
EWO Audiometer
Reason for recall
Affected lots of product may experience technical distortions to a greater extent than expected.
FDA root cause
Process change control
Action
An URGENT: MEDICAL DEVICE RECALL SENTIERO notification letter dated 9/26/23 was sent to customers. Actions to be taken by the User: The technical distortions can influence the specified performance of the device when performing diagnostic DPOAEs at high stimuli. Therefore, PATH MEDICAL chose to voluntarily recall affected products for correction. 1. Immediately identify any affected devices at your location and quarantine them. 2. Please return your affected device(s) to your local distributor or PATH MEDICAL directly (Shipping Address: Landsberger Str. 65, 82110 Germering, Germany) to have your PCB replaced. Upon request, return labels can be provided. 3. If the device(s) have been further distributed to other accounts, please forward this notice to them to inform them of the recall. 4. Report any adverse events to FDA MedWatch: Use the MedWatch Online Reporting Form or call 800-332-1088. Re-Screening of patients screened with a device subject to the recall is not necessary, as regular DPAOE screening would not be done at stimuli as high as they would be affected by the issue. Furthermore, DPOAE-based hearing screening always consists of measurements at multiple frequencies. Therefore, false positive DPOAE detections at a single frequency, which are already considered unlikely, would not necessarily falsify the overall screening result (e.g., pass criterion 3 out of 4). Please be aware that your local competent authority may have been informed of this recall, if required by law. Thank you for your cooperation. In case there are additional questions, please contact us under: Mail: [email protected] Phone: +49 (0)89 80076502
Quantity in commerce
1 unit
Distribution
US States: FL, MO, OH, WI
Product codes and lots
UDI-DI: 04260223142475; Serial Numbers: 280117

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0404-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0401-2024Class IIOngoingVoluntary: Firm initiated
Z-0402-2024Class IIOngoingVoluntary: Firm initiated
Z-0403-2024Class IIOngoingVoluntary: Firm initiated
Z-0404-2024Class IIOngoingVoluntary: Firm initiated